project id: TCGA-STAD; case submitter id: TCGA-HU-A4H3; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 7.9; age at index: 56; days to birth: -20790; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1955; age at diagnosis: 20790; ajcc pathologic m: M0; ajcc pathologic n: N3b; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 882.0; icd 10 code: C16.2; last known disease status: not reported; morphology: 8145/3; primary diagnosis: Carcinoma, diffuse type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Body of stomach; synchronous malignancy: No; tissue or organ of origin: Body of stomach; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 467; initial weight: 210.0; oct embedded: false; preservation method: Unknown; sample id: cd33e854-1bdf-42e0-83e7-256c723c5b55; sample submitter id: TCGA-HU-A4H3-01A; portion id: 5faca899-d483-4263-b74b-4855bac64737; portion submitter id: TCGA-HU-A4H3-01A-21; slide id: bf61dfef-e08f-4dc1-b807-02d853cce143; slide submitter id: TCGA-HU-A4H3-01A-02-TS2; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 0.0; percent necrosis: 15.0; percent neutrophil infiltration: 0.0; percent normal cells: 25.0; percent stromal cells: 22.0; percent tumor cells: 38.0; percent tumor nuclei: 75.0; section location: TOP;